394 related articles for article (PubMed ID: 11418871)
21. Guidelines for preventing infectious complications among hematopoietic cell transplant recipients: a global perspective.
; ; ; ; ; ; ; ;
Bone Marrow Transplant; 2009 Oct; 44(8):453-558. PubMed ID: 20095071
[No Abstract] [Full Text] [Related]
22. [Supportive therapy in patients with autologous hemopoietic stem cell transplantation].
Piatkowska-Jakubas B; Hawrylecka D; Wójcik M; Skotnicki AB
Przegl Lek; 1999; 56 Suppl 1():108-14. PubMed ID: 10494191
[TBL] [Abstract][Full Text] [Related]
23. Viral infections in transplant recipients.
Razonable RR; Eid AJ
Minerva Med; 2009 Dec; 100(6):479-501. PubMed ID: 20010483
[TBL] [Abstract][Full Text] [Related]
24. [Ambulatory therapy and prevention of the most frequent HIV-associated opportunistic infections].
Malinverni R; Blatter M
Schweiz Med Wochenschr; 1991 Aug; 121(34):1194-204. PubMed ID: 1925448
[TBL] [Abstract][Full Text] [Related]
25. [Guidelines for vaccination following hematopoietic stem cell transplantation].
Azuma E
Rinsho Ketsueki; 2009 Aug; 50(8):642-51. PubMed ID: 19915379
[No Abstract] [Full Text] [Related]
26. Severe infections after allogeneic peripheral blood stem cell transplantation: a matched-pair comparison of unmanipulated and CD34+ cell-selected transplantation.
Martino R; Rovira M; Carreras E; Solano C; Jorge S; De La Rubia J; Caballero MD; de Oteyza JP; Zuazu J; Moraleda JM; Ojeda E; Ferrá C; Serrano D; De La Cámara R; Urbano-Ispízua A; Brunet S;
Haematologica; 2001 Oct; 86(10):1075-86. PubMed ID: 11602414
[TBL] [Abstract][Full Text] [Related]
27. Fluoroquinolone resistance in hematopoietic stem cell transplant recipients with infectious complications.
Bonadio M; Morelli G; Mori S; Riccioni R; Papineschi F; Petrini M
Biomed Pharmacother; 2005 Oct; 59(9):511-6. PubMed ID: 16274955
[TBL] [Abstract][Full Text] [Related]
28. Prophylaxis of infection in bone marrow transplants.
Winston DJ; Ho WG; Gale RP; Champlin RE
Eur J Cancer Clin Oncol; 1988; 24 Suppl 1():S15-23. PubMed ID: 3127217
[TBL] [Abstract][Full Text] [Related]
29. Infections in allogeneic bone marrow transplant recipients.
Wingard JR
Semin Oncol; 1993 Oct; 20(5 Suppl 6):80-7. PubMed ID: 8211220
[TBL] [Abstract][Full Text] [Related]
30. Antimicrobial prophylaxis in febrile neutropenia.
Yoshida M; Ohno R
Clin Infect Dis; 2004 Jul; 39 Suppl 1():S65-7. PubMed ID: 15250025
[TBL] [Abstract][Full Text] [Related]
31. A randomised trial comparing cytomegalovirus antigenemia assay vs screening bronchoscopy for the early detection and prevention of disease in allogeneic bone marrow and peripheral blood stem cell transplant recipients.
Humar A; Lipton J; Welsh S; Moussa G; Messner H; Mazzulli T
Bone Marrow Transplant; 2001 Sep; 28(5):485-90. PubMed ID: 11593322
[TBL] [Abstract][Full Text] [Related]
32. Guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients. Recommendations of CDC, the Infectious Disease Society of America, and the American Society of Blood and Marrow Transplantation.
CDC, Infectious Disease Society of America, and the American Society of Blood and Marrow Transplantation
Cytotherapy; 2001; 3(1):41-54. PubMed ID: 12028843
[No Abstract] [Full Text] [Related]
33. Guidelines for preventing opportunistic infections among HIV-infected persons--2002. Recommendations of the U.S. Public Health Service and the Infectious Diseases Society of America.
Masur H; Kaplan JE; Holmes KK; ;
Ann Intern Med; 2002 Sep; 137(5 Pt 2):435-78. PubMed ID: 12617574
[TBL] [Abstract][Full Text] [Related]
34. Occurrence of Pneumocystis jiroveci pneumonia after allogeneic stem cell transplantation: a 6-year retrospective study.
De Castro N; Neuville S; Sarfati C; Ribaud P; Derouin F; Gluckman E; Socié G; Molina JM
Bone Marrow Transplant; 2005 Nov; 36(10):879-83. PubMed ID: 16151423
[TBL] [Abstract][Full Text] [Related]
35. Randomized clinical trial of ganciclovir vs acyclovir for prevention of cytomegalovirus antigenemia after allogeneic transplantation.
Burns LJ; Miller W; Kandaswamy C; DeFor TE; MacMillan ML; Van Burik JA; Weisdorf DJ
Bone Marrow Transplant; 2002 Dec; 30(12):945-51. PubMed ID: 12476289
[TBL] [Abstract][Full Text] [Related]
36. Monitoring human cytomegalovirus infection in transplant recipients.
Baldanti F; Lilleri D; Gerna G
J Clin Virol; 2008 Mar; 41(3):237-41. PubMed ID: 18203657
[TBL] [Abstract][Full Text] [Related]
37. [Histopathological diagnosis of opportunistic infection].
Tsutsumi Y
Rinsho Byori; 2002 Jul; 50(7):649-57. PubMed ID: 12187700
[TBL] [Abstract][Full Text] [Related]
38. Antifungal prophylaxis among allogeneic hematopoietic stem cell transplant recipients: current issues and new agents.
Strasfeld L; Weinstock DM
Expert Rev Anti Infect Ther; 2006 Jun; 4(3):457-68. PubMed ID: 16771622
[TBL] [Abstract][Full Text] [Related]
39. Valacyclovir for the prevention of cytomegalovirus infection after allogeneic stem cell transplantation: a single institution retrospective cohort analysis.
Vusirikala M; Wolff SN; Stein RS; Brandt SJ; Morgan DS; Greer JP; Schuening FG; Dummer JS; Goodman SA
Bone Marrow Transplant; 2001 Aug; 28(3):265-70. PubMed ID: 11535994
[TBL] [Abstract][Full Text] [Related]
40. Severe infections after unrelated donor allogeneic hematopoietic stem cell transplantation in adults: comparison of cord blood transplantation with peripheral blood and bone marrow transplantation.
Parody R; Martino R; Rovira M; Vazquez L; Vázquez MJ; de la Cámara R; Blazquez C; Fernández-Avilés F; Carreras E; Salavert M; Jarque I; Martín C; Martínez F; López J; Torres A; Sierra J; Sanz GF;
Biol Blood Marrow Transplant; 2006 Jul; 12(7):734-48. PubMed ID: 16785063
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
